The upregulation was less pronounced in all triple negative, basal type cancer cells, MDA-MB-468, BT-549, MDA-MB-231, Hs578T and in the non-tumorigenic MCF-10A cell line and in the HER2 positive AU-565 cells. Here, ERBB2 is linked to cancer.